MARATTO

article · Biomedicine & Pharmacotherapy

Retraction notice to "Nephroprotective effect of AT-MSCs against cisplatin-induced EMT is improved by azilsartan via attenuating oxidative stress and TGF-β/Smad signaling" [Biomedicine & Pharmacotherapy 158 (2023) 114097]

2026Open accessDamanhour University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Chemotherapy-induced organ toxicity mitigation
  • Advanced Breast Cancer Therapies
  • PI3K/AKT/mTOR signaling in cancer

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1016/j.biopha.2026.119460

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.